ArticleJournal of the Egyptian National Cancer Institute2025
Clinical implementation of a multifaceted quality assurance phantom for high-precision radiation therapy: an institutional experience.
Article in Journal of the Egyptian National Cancer Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- [Image-guided application of plant pigment patch and laser microdot ablation for surface marking in radiotherapy for breast cancer: a randomized controlled trial].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026Trial
- Bridging precision and practice: dual validation of a high-resolution detector array for beam profiling and patient QA in robotic radiosurgery.Physical and engineering sciences in medicine · 2026Article
- A Review of 3D-Printed Medical Devices for Cancer Radiation Therapy.Bioengineering (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study aimed to evaluate the multifaceted clinical utility of the RUBY phantom as a comprehensive quality assurance (QA) platform in high-precision radiotherapy, particularly for stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT). The objective was to validate its performance in patient positioning, imaging system accuracy, isocenter congruency, and treatment plan verification across various complex clinical scenarios. MATERIALS AND
methodsA series of QA workflows were conducted using the RUBY phantom and its dedicated modular inserts. These included CBCT and MV/kV planar imaging for patient alignment, the Winston-Lutz insert for isocenter verification, end-to-end testing for full-chain validation, and multi-metastasis and patient-specific inserts for point dose verification. Plans were created in Eclipse TPS (v15.6) and delivered using a Varian TrueBeam STx linear accelerator with high-definition MLC. PTW Semiflex 3D and PinPoint 3D ionization chambers were used for all dosimetric verifications.
resultsCBCT- and planar image-guided alignments showed sub-millimetric deviations, with post-correction alignment verified through coincident laser and surface markers. Winston-Lutz testing across various angles demonstrated maximal deviations of ≤ 0.4 mm, which was within TG-142 recommendations. Point dose measurements for 61 SRS plans showed agreement within ± 3% of TPS calculations. End-to-end testing revealed dose discrepancies of < 1% in both coplanar and non-coplanar beam arrangements. Multi-target plans using single- and multi-isocenter approaches showed deviations of - 0.23% to - 0.50%, confirming excellent dosimetric and geometric accuracy.
conclusionThe RUBY phantom demonstrated exceptional precision, reproducibility, and clinical adaptability across a spectrum of advanced radiotherapy QA tasks. Its integration enables the end-to-end validation of modern treatment protocols, ensuring alignment, imaging, and accuracy of dose delivery. These findings establish the RUBY phantom as a cornerstone QA solution for enhancing safety, efficacy, and reliability in high-precision radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.